Advent Capital Management’s Celgene Corp CELG Stock Holding History

Advent Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-28,000	Closed	-$2.64M	–	244
2019 Q1	$2.64M	Buy	+28,000	New	+$2.45M	0.06%	148
2018 Q1	–	Sell	-40,000	Closed	-$4.17M	–	323
2017 Q4	$4.17M	Buy	+40,000	New	+$4.51M	0.08%	149
2014 Q2	–	Sell	-32,924	Closed	-$2.3M	–	494
2014 Q1	$2.3M	Buy	+32,924	New	+$2.61M	0.04%	294
2013 Q4	–	Sell	-6,324	Closed	-$500K	–	443
2013 Q3	$487K	Sell	6,324 -276	-4%	-$19.3K	0.01%	530
2013 Q2	$386K	Buy	+6,600	New	+$397K	0.01%	491

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Advent Capital Management's CELG Position: Q2 2019 in Review

Advent Capital Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 28,000 shares — an estimated $2.64M sold.

Advent Capital Management first reported a position in CELG in Q2 2013 and held it in 5 quarters. The position peaked at $4.17M in Q4 2017. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Advent Capital Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Advent Capital Management sold 28,000 Celgene Corp shares in Q2 2019, an estimated $2.64M.
Advent Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 5 quarters.
Advent Capital Management's Celgene Corp position peaked at $4.17M in Q4 2017.
1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Advent Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.